Search PubMed⌕ Search

Biomedical subjects

M Reimer

Publications and source records attributed to M Reimer.

At least 19 recordsLinked to original sources

Effect of manure on glyphosate and trifluralin mineralization in soil.

Manure additions to soil may alter soil chemical, physical, and biological characteristics, and thereby change pesticide fate processes in soil. This is the first study to examine the impact of liquid hog manure amendments on glyphosate and trifluralin mineralization in soil. Experiments were conducted in soil microcosms in the laboratory for a total of 332 (glyphosate) and 430 (trifluralin) days. The rate and amount of mineralization of both glyphosate and trifluralin were significantly influenced by the additions of fresh manure to soil in the laboratory and by the history of manure applications in the field. However, the maximum difference in herbicide mineralization between soils that were free of manure application and those amended with manure in the field or in the laboratory was only 6.1% and 7.3% of that initially applied, for trifluralin and glyphosate, respectively. Therefore, we conclude that liquid hog manure application to soil will have no significant effect on the mineralization of glyphosate and trifluralin under field conditions.

Animals↗

Nurses begin a national plan for the integration of supportive care in health research, practice, and policy.

The demand for and use of health, social, and other human services is related not to the type or severity of disease but rather to a person's socio-economic, cognitive, and emotional characteristics and environmental circumstances. A workshop on supportive care was held to promote a robust research environment, the creation of new knowledge, the setting of an integrated health research agenda, a focusing of attention on the evolving health-care system, and anticipation of emerging health challenges. While the workshop was intended to address a research mandate for the Canadian Institutes of Health Research, a larger vision emerged, to include advocacy, information system, surveillance, and policy development required by institutional, community, voluntary, private sector, family caregiver, and provider systems. The development of a national supportive care strategy will enable Canadians with disease and disability to live with all of their challenges, and could engage researchers, clinicians, advocacy groups, and people experiencing major health challenges.

Canada↗

Increased expression, axonal transport and release of pituitary adenylate cyclase-activating polypeptide in the cultured rat vagus nerve.

The expression and axonal transport of pituitary adenylate cyclase-activating polypeptide (PACAP) was studied in the cultured vagus nerve of the rat by immunocytochemistry and in situ hybridization. The number of neurons immunoreactive for PACAP increased markedly within the nodose ganglion during a 24-48 h culture period, as did the number of cells containing messenger RNA for PACAP. PACAP was found to be axonally transported and accumulated at the site of a crush injury. The peptide was also released at this site. Addition of PACAP to regenerating nerves in culture did not affect axonal outgrowth, neither did antibodies against PACAP. Separate experiments showed that neither PACAP-27 nor PACAP-38 affected proliferation of non-neuronal cells measured as the incorporation of [3H]thymidine. In contrast, forskolin, another potent stimulator of adenylate cyclase besides PACAP, dramatically decreased [3H]thymidine incorporation. The results showed that, during regeneration of peripheral nerves, PACAP expression increases and the peptide is transported into the regenerating nerve, where it is released. The functional significance of this release is unknown, but it does not seem to be directly related to the initiation of proliferation of Schwann cells or initial axonal outgrowth.

Animals↗

Peripheral but not central axotomy promotes axonal outgrowth and induces alterations in neuropeptide synthesis in the nodose ganglion of the rat.

We investigated the effects of central and peripheral axotomy of the sensory neurons in the nodose ganglion on neurite outgrowth and neuropeptide expression. Axonal outgrowth was studied in ganglia subjected to a conditioning lesion of the vagus nerve 6 days prior to in vitro explantation. In such cultures, a conditioning effect, i. e. a shorter initial delay and faster axonal outgrowth, was observed after peripheral axotomy, while central axotomy had no effect. Neuropeptide expression was measured by immunocytochemistry 3 days after axotomy. Peripheral axotomy induced an increase in the number of neurons expressing the C-terminal flanking peptide of neuropeptide Y (C-PON), galanin (GAL) and vasoactive intestinal peptide (VIP). In contrast, central axotomy did not affect neuropeptide expression. These results suggest that both axonal outgrowth and expression of neuropeptides in the sensory neurons of the nodose ganglion could be regulated by the contact of the cells with their peripheral, but not their central targets.

Animals↗

Regeneration of axons from central neurons into microchips at the level of the spinal cord.

Axons from central neurons can regenerate into the tissue matrix formed within a silicone tube capped with two pieces of peripheral nerve, one of which had been sutured to a lesion in the spinal cord. Such axons can grow through a transversely positioned microchip in the tube. These observations suggest that it is feasible to establish functional contact between external electronic equipment and regenerating central nervous axons making it possible to monitor and control their electrical activity. The findings open new perspectives for restoration of motor and sensory functions following spinal cord lesions.

Animals↗

The effects of axotomy and preganglionic denervation on the expression of pituitary adenylate cyclase activating peptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion.

The effects of axotomy, chemical sympathectomy and preganglionic denervation on the expression of the neuropeptides, pituitary adenylate cyclase-activating peptide (PACAP), galanin (GAL), and the PACAP type 1 receptor in the rat superior cervical ganglion (SCG) were investigated by immunocytochemistry, in situ hybridization and receptor autoradiography. An antibody recognizing the rat vesicular acetylcholine transporter (VAChT) was used for the detection of preganglionic cholinergic fibers. In the normal SCG, PACAP-immunoreactivity (-IR) was present in numerous, basket-forming, preganglionic nerve fibers, while very few SCG neurons expressed PACAP. GAL-IR was restricted to occasional neurons, and a few nerve fibers, most of which were, in addition, PACAP-IR. PACAP type 1 receptors were expressed in all nerve cell bodies. Axotomy resulted in a rapid and prominent upregulation of PACAP in a large number of nerve cell bodies. There was a large increase also in GAL expression in many nerve cell bodies. In contrast, there was a marked decline in PACAP type 1 receptor expression. Chemical sympathectomy by administration of the catcholaminergic neurotoxin, 6-hydroxydopamine (6-OHDA), gave rise to similar changes. Preganglionic denervation led to the disappearance of PACAP- and VAChT-IR baskets and to the upregulation of PACAP and GAL expression in neurons located close to the entrance of the sympathetic chain, whereas PACAP type 1 receptor expression was not affected. PACAP and GAL were coexpressed in most neurons after axotomy and chemical sympathectomy. Taken together, these results indicate that disruption of target contact and/or the infliction of an injury to the axons of the sympathetic neurons, rather than the preganglionic output, regulates the expression of PACAP, GAL and the PACAP type 1 receptor.

Animals↗

Pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type 1 receptor expression in regenerating adult mouse and rat superior cervical ganglia in vitro.

Pituitary adenylate cyclase-activating polypeptide (PACAP), a regulatory peptide belonging to the vasoactive intestinal peptide (VIP) family, is widely distributed in the central and peripheral nervous system. Recent studies have shown that PACAP expression is upregulated in sensory neurons in response to axonal injury. Here we report that PACAP and PACAP type 1 receptors are located in rat and mouse superior cervical ganglia (SCG). PACAP-immunoreactivity (-IR) was demonstrated in preganglionic fibers, whereas only occasional PACAP-IR cell bodies could be observed. In situ hybridization histochemistry using 35S-labeled deoxyribonucleotide probes confirmed that PACAP mRNA was present only in occasional cell bodies. In contrast, PACAP type 1 receptor mRNA was expressed in virtually all cell bodies within the ganglia. After removal and culturing of the SCG for 24 h, there was a marked increase in PACAP mRNA, whilst PACAP type 1 receptor mRNA expression appeared to be downregulated in most nerve cell bodies except for a few scattered neurons displaying a strong upregulation. The total specific binding of PACAP to isolated SCG membranes as assayed by [125I]PACAP-27 binding showed an increase in SCG cultured for 48 h. PACAP-27 neither affected axonal outgrowth from the cultured SCG nor the survival of cells within the SCG. We conclude that PACAP and PACAP receptors are rapidly upregulated in sympathetic ganglia in response to axonal injury and that PACAP may play a role during nerve regeneration.

Animals↗

Comparative results of bracing and interlocking nailing in the treatment of humeral shaft fractures.

A comparison was made between 44 humeral fractures treated conservatively with functional bracing (Group 1) and 45 treated by operation with a locking nail (Group 2). Thirty-eight of the 44 patients in Group 1 (86%) and 22 of the 45 patients in Group 2 (47%) regained full movement of the shoulder joint. The functional end results were somewhat better in Group 1 although over 90% of patients in both groups were able to clasp their fingers behind their necks and to reach up their backs without restriction. Two patients developed a pseudarthrosis in Group 1, and 2 patients in Group 2 required operative revision due to a haematoma in 1 case and as a result of an infection in the other. There were 6 cases of primary radial nerve damage in both groups, and 6 had to be decompressed operatively. Residual sensory and motor disturbance remained in 2 patients in Group 1. Both methods are useful for the treatment of humeral shaft fractures. We advocate functional bracing as the method of choice if no contraindications exist.

Adolescent↗

Functional treatment of humeral shaft fractures: indications and results.

OBJECTIVE: To determine effectiveness of closed functional bracing for humeral shaft fractures. DESIGN: Retrospective. SETTING: University. PATIENTS: Eighty-seven patients with humeral shaft fractures. INTERVENTION: All patients were treated with closed functional bracing. MAIN OUTCOMES MEASURED: Both subjective and objective criteria were measured. Objective criteria consisted of range of motion and radiographic measurements. Subjective data were recorded using the Hannover Shoulder Score. RESULTS: Eighty-six percent of the follow-up group showed no restrictions in the movement of their shoulder and elbow joints. On the basis of subjective criteria, 95% of the patients were content with the functional treatment, 65% claimed to be pain free in their daily activities and at work, and 35% felt pain only when doing vigorous activities or heavy physical work. Although malposition with an angulation greater than 10 degrees was observed in ten patients (12.6%), functional outcome was good or excellent in two thirds of the cases followed up. CONCLUSIONS: When the correct indications are present, functional treatment of humeral shaft fractures has proven to be an excellent method that is both reliable and cost effective.

Adolescent↗

Indicators of quality in long-term care facilities.

Quality of care is of particular importance to residents of long-term care facilities because of the permanency of their situation. In this study indicators of quality of care were generated from data obtained at a primary level from those most affected by the care. The critical incident technique was used to identify the indicators as perceived by 52 residents, 58 significant others, and 37 nursing staff in five long-term care facilities in Calgary, Canada. The 14 major indicators so identified are discussed in this paper.

Aged↗

[Morphometric findings of the healthy pediatric gallbladder in ultrasound].

AIM: Ultrasonographic determination of gallbladder wall thickness, volume and excretion in children. METHOD: In 76 children (1-16 years) we determined the volume of the fasting and stimulated gallbladder by the ellipsoid formula (length X width X depth X 0.523). We also measured the gallbladder wall thickness. Stimulation was performed with a standardised breakfast. RESULTS: We always measured the gallbladder wall thickness 3 mm or less and did not find a difference between fasting and stimulation. There was no correlation between gallbladder wall thickness and status of contraction. The healthy gallbladder should excrete at least 25% of the fasting volume within 1 hour. CONCLUSION: Ultrasound is a suitable method to determine the excretion of the gallbladder. In children standardised meals can be used as stimulus instead of commercial stimulating meals.

Adolescent↗

Wear of CAD/CAM ceramic inlays: restorations, opposing cusps, and luting cements.

Six standard mesio-occlusodistal restorations in extracted mandibular human molars and six opposing palatal cusps from maxillary human first molars were prepared per group. The occlusal contact areas of the restorations and of the opposing enamel cusps were digitized with a three-dimensional scanner. The specimens were exposed to a clinically correlated long-term in vitro wear test. Dicor MGC, Cerec Vita Mk I porcelain, Cerec Vita Mk II V7R porcelain, and Cerec Mk II Vita V7K porcelain were tested. The mean wear of these ceramic materials at the end of the long-term test ranged from 24.3 +/- 10.3 microns (Cerec Vita Mk II V7R) to 88.0 +/- 37.3 microns (Dicor MGC). The mean wear of the opposing human enamel cusps ranged from 93.5 +/- 30.8 microns (Cerec Vita Mk II V7R) to 224.3 +/- 117.4 microns (Cerec Vita Mk I). All ceramic materials except Dicor MGC wore less than did previously measured standards, such as natural human enamel and amalgam. However, because the wear of opposing enamel cusps was high with Dicor MGC and with Cerec Vita Mk I the total wear of these two materials--the sum of the restoration's and the opposing tooth's wear--was higher than that of the standards. Only the new fine porcelain Cerec Vita Mk II V7R showed a total wear comparable to that of enamel, because of its moderate abrasivity against opposing enamel. The wear of the two luting composite resins was measured at the end of the test. Both luting composite resins wore more than did the ceramic inlays and surrounding enamel, leaving a shallow ditch around the restorations.

Ceramics↗

Wear of ceramic inlays, their enamel antagonists, and luting cements.

The wear of ceramic inlay materials and antagonist enamel cups was measured in vitro. Per group, six MOD inlays were adhesively cemented in extracted molars. Castable glass ceramic, pressed glass ceramic, and feldspathic porcelain were used as inlay materials. A microfilled and a fine hybrid composite served as luting agents. The restorations were exposed to an in vitro wear test that corresponds to approximately 5 years of clinical service. The wear in the occlusal contact area was quantified during and at the end of the test with a three-dimensional scanner. Final wear measurements on the inlays (mean +/- SD) ranged from 21.8 +/- 8.8 microns for pressed glass ceramic to 59.0 +/- 37.9 microns for castable glass ceramic. The mean wear of the enamel antagonists ranged from 74.6 +/- 32.9 microns for pressed glass ceramic to 153.2 +/- 61.5 microns for feldspathic porcelain. The wear of the luting composites at the end of the test ranged from 4.9 +/- 5.1 microns for microfilled to 12.3 +/- 6.3 microns for fine hybrid.

Aluminum Silicates↗